| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |